Healthcare Global Point-of-care Testing Growth Opportunities Updated Research Available

Molecular POCT Unlocking Growth Potential in the Distributed Diagnostic Data Ecosystem

INDUSTRY
Healthcare

RELEASE DATE
15-Nov-2023
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
K973-01-00-00-00
SKU
HC_2023_319
Yes
SHARE

Global Point-of-care Testing Growth Opportunities
Published on: 15-Nov-2023 | SKU: HC_2023_319

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

This study provides an overview of the global point-of-care testing (POCT) industry, which refers to any routine or specialized lab pathology
testing conducted rapidly, on-site/near the site of the patient, where care or treatment is provided. COVID-19 radicalization is changing the global diagnostics landscape. Consolidation trends, structural shifts in healthcare settings, and the extension of POCT to sexually transmitted infections (STIs), antimicrobial resistance (AMR), routine testing, oncology, and newborn screening are shaping new frontiers. In the future, therapy areas such as oncology, stroke, and dementia will represent the POCT repertoire.

In developed economies, the proliferation of syndromic testing, multiplexing making inroads in immunoassay, evolution in nucleic acid
amplification technology (from PCR to Isothermal Amplification), the use of saliva specimens, and advancements in antimicrobial resistance
testing are increasing the market viability. Furthermore, AI/ML-enabled device software functions incorporating predetermined change control
plans under the diagnostic data program initiative offer accelerated market opportunities in the United States.

In developing economies, multiparametric platforms have emerged to respond to an escalating POC demand in emergency departments and
small-medium labs. In addition, a strong pull toward preventive health is laying the foundation to advance routine testing using emerging blood testing platforms.

A robust multiplex ecosystem tied with the converging potential of diagnostic data creating new revenue streams (e.g., connectivity and digital healthcare technology services) exemplifies the pivot from COVID-19 testing, adapting to changing clinical pathways and greater harmonization
of lab-based and non-lab-based diagnostic data for similar tests to build a more sustainable point-of-care ecosystem.

Author: Amartya Bose

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Point-of-care Testing (POCT) Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of Analysis

Scope of Analysis (continued)

Segmentation—Test Type

Segmentation—Care Continuum

Key Competitors

Growth Metrics

Growth Drivers

Growth Drivers (continued)

Growth Restraints

Growth Restraints (continued)

Forecast Assumptions

Revenue Forecast

Revenue Forecast by Test Type

Revenue Forecast by Region

Revenue Forecast by Care Continuum

Forecast Analysis

Forecast Analysis (continued)

Forecast Analysis (continued)

Forecast Analysis (continued)

Forecast Analysis (continued)

Forecast Analysis (continued)

Pricing Trends and Forecast Analysis

Competitive Environment

POCT Across Different Therapy Areas

Revenue Share

Revenue Share Analysis

Revenue Share Analysis (continued)

Revenue Share Analysis (continued)

Revenue Share Analysis (continued)

Competitor Matrix—Therapy Areas

Competitor Matrix—Technology Mapping

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

Revenue Forecast by Immunochemistry POCT

Forecast Analysis

Forecast Analysis (continued)

Forecast Analysis (continued)

Forecast Analysis (continued)

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

Revenue Forecast by Molecular POCT Therapy Areas

Forecast Analysis

Forecast Analysis (continued)

Forecast Analysis (continued)

Forecast Analysis (continued)

Growth Opportunity 1: Molecular POCT

Growth Opportunity 1: Molecular POCT (continued)

Growth Opportunity 2: Multiplexing

Growth Opportunity 2: Multiplexing (continued)

Growth Opportunity 3: STI POCT

Growth Opportunity 3: STI POCT (continued)

Growth Opportunity 4: AMR POCT

Growth Opportunity 4: AMR POCT (continued)

Growth Opportunity 5: Routine POCT

Growth Opportunity 5: Routine POCT (continued)

Growth Opportunity 6: Smartphone POCT

Growth Opportunity 6: Smartphone POCT (continued)

Future of POCT in Care Continuum

Your Next Steps

Why Frost, Why Now?

List of Exhibits

Legal Disclaimer

List of Figures
  • POCT Industry: Growth Metrics, Global, 2023
  • POCT Industry: Growth Drivers, Global, 2024–2028
  • POCT Industry: Growth Restraints, Global, 2024–2028
  • POCT Industry: Revenue Forecast, Global, 2023–2028
  • POCT Industry: Revenue Forecast by Test Type, Global, 2023–2028
  • POCT Industry: Revenue Forecast by Region, 2023–2028
  • POCT Industry: Revenue Forecast by Care Continuum, Global, 2023–2028
  • POCT Industry: Revenue Share of Top Participants, Global, 2023
  • POCT Industry: Competitor Matrix for Therapy Area Portfolio Assessment, Global, 2023
  • Immunochemistry POCT: Growth Metrics, Global, 2023
  • Immunochemistry POCT: Revenue Forecast, Global, 2023–2028
  • Immunochemistry POCT: Revenue Forecast by Region, 2023–2028
  • Immunochemistry POCT Industry: Revenue Forecast by Therapy Areas, 2023–2028
  • Molecular POCT: Growth Metrics, Global, 2023
  • Molecular POCT: Revenue Forecast, Global, 2023–2028
  • Molecular POCT: Revenue Forecast by Region, 2023–2028
  • Molecular POCT Industry: Revenue Forecast by Therapy Areas, Global, 2023–2028

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

08 Oct 2026   |   Global   |   Frost Radar

Frost Radar: Endoscopy Device Technology Ecosystem, 2026

The endoscopy device market is advancing toward higher-quality visualization and improved clinical decision-making, with innovation across 4K ultrahigh-definition display systems, image-enhanced endoscopy, and computer-aided detection systems. Advanced visualization is evolving through improvements ...

07 Oct 2026   |   Global   |   Technology Research

Growth Opportunities in Image-Guided Cancer Ablation Systems

Image-guided cancer ablation systems are minimally invasive medical technologies that use real-time imaging to accurately guide the placement of an ablation device into a tumor, enabling localized destruction of cancerous tissue while minimizing damage to surrounding healthy structures.The increasin...

06 Oct 2026   |   Global   |   Technology Research

Trends in Laboratory Automation, Global, 2021–2025

This research study provides a comprehensive assessment of the recent trends, technological advancements, and strategic developments shaping the global laboratory automation industry. The analysis traces the evolution of laboratory automation from task-specific automation systems to integrated, inte...

05 Oct 2026   |   Global   |   Frost Radar

Frost Radar™: Point-of-Care Ultrasound Imaging Technology Ecosystem, 2026

The point-of-care ultrasound imaging industry is undergoing a fundamental transformation from equipment-intensive ultrasound to portable, handheld, wireless, AI-enabled, and connected point-of-care solutions. Driven by the need for rapid bedside diagnosis and decentralized healthcare delivery, speci...

25 Sep 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Advanced Medical Devices, Diagnostic Solutions, and Implantables

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantables.The issue features advanced medical devices such as peritoneal dialysis fluid system, cold sterilization-based au...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

This study provides an overview of the global point-of-care testing (POCT) industry, which refers to any routine or specialized lab pathology testing conducted rapidly, on-site/near the site of the patient, where care or treatment is provided. COVID-19 radicalization is changing the global diagnostics landscape. Consolidation trends, structural shifts in healthcare settings, and the extension of POCT to sexually transmitted infections (STIs), antimicrobial resistance (AMR), routine testing, oncology, and newborn screening are shaping new frontiers. In the future, therapy areas such as oncology, stroke, and dementia will represent the POCT repertoire. In developed economies, the proliferation of syndromic testing, multiplexing making inroads in immunoassay, evolution in nucleic acid amplification technology (from PCR to Isothermal Amplification), the use of saliva specimens, and advancements in antimicrobial resistance testing are increasing the market viability. Furthermore, AI/ML-enabled device software functions incorporating predetermined change control plans under the diagnostic data program initiative offer accelerated market opportunities in the United States. In developing economies, multiparametric platforms have emerged to respond to an escalating POC demand in emergency departments and small-medium labs. In addition, a strong pull toward preventive health is laying the foundation to advance routine testing using emerging blood testing platforms. A robust multiplex ecosystem tied with the converging potential of diagnostic data creating new revenue streams (e.g., connectivity and digital healthcare technology services) exemplifies the pivot from COVID-19 testing, adapting to changing clinical pathways and greater harmonization of lab-based and non-lab-based diagnostic data for similar tests to build a more sustainable point-of-care ecosystem. Author: Amartya Bose
More Information
Deliverable Type Market Research
Author Amartya Bose
Industries Healthcare
No Index No
Is Prebook No
Keyword 1 Point Of Care Molecular Diagnostics
Keyword 2 Poc Testing Trends
Keyword 3 Point-Of-Care Testing Insights
List of Charts and Figures POCT Industry: Growth Metrics, Global, 2023~ POCT Industry: Growth Drivers, Global, 2024–2028~ POCT Industry: Growth Restraints, Global, 2024–2028~ POCT Industry: Revenue Forecast, Global, 2023–2028~ POCT Industry: Revenue Forecast by Test Type, Global, 2023–2028~ POCT Industry: Revenue Forecast by Region, 2023–2028~ POCT Industry: Revenue Forecast by Care Continuum, Global, 2023–2028~ POCT Industry: Revenue Share of Top Participants, Global, 2023~ POCT Industry: Competitor Matrix for Therapy Area Portfolio Assessment, Global, 2023~ Immunochemistry POCT: Growth Metrics, Global, 2023~ Immunochemistry POCT: Revenue Forecast, Global, 2023–2028~ Immunochemistry POCT: Revenue Forecast by Region, 2023–2028~ Immunochemistry POCT Industry: Revenue Forecast by Therapy Areas, 2023–2028~ Molecular POCT: Growth Metrics, Global, 2023~ Molecular POCT: Revenue Forecast, Global, 2023–2028~ Molecular POCT: Revenue Forecast by Region, 2023–2028~ Molecular POCT Industry: Revenue Forecast by Therapy Areas, Global, 2023–2028~
Podcast No
WIP Number K973-01-00-00-00

Global Point-of-care Testing Growth Opportunities

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC_2023_319